Miltenyi Biomedicine

Anna Wijatyk, M.D., Chief Medical Officer

Oct. 12 | 2:30pm | Oxford Biomedica Ballroom  

Waltham, MA 


In-person Presentation 

Miltenyi Biomedicine is a newly established biopharmaceutical company that develops innovative cell and gene therapies. We are committed to bringing cancer treatments and regenerative therapies to patients worldwide. 

By using this website you agree to accept our Privacy Policy and Terms & Conditions